5AM Opportunities I, L.P.'s Net Worth

$173 Million

Estimate Recalculated Aug 20, 2024 03:36PM EST

Who is 5AM Opportunities I, L.P.?

5AM Opportunities I, L.P. has an estimated net worth of $173 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., CinCor Pharma, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Pear Therapeutics, Inc., Rallybio Corp, scPharmaceuticals Inc., Akouos, Inc., IDEAYA Biosciences, Inc., IMPEL NEUROPHARMA INC, Cabaletta Bio, Inc., and Aprea Therapeutics, Inc..

SEC CIK

5AM Opportunities I, L.P.'s CIK is 0001753000

Past Insider Trading and Trends

2021 was 5AM Opportunities I, L.P.'s most active year for acquiring shares with 18 total transactions. 5AM Opportunities I, L.P.'s most active month to acquire stocks was the month of September. 2022 was 5AM Opportunities I, L.P.'s most active year for disposing of shares, totalling 56 transactions. 5AM Opportunities I, L.P.'s most active month to dispose stocks was the month of October. 2022 saw 5AM Opportunities I, L.P. paying a total of $25,520,000.00 for 4,937,646 shares, this is the most they've acquired in one year. In 2020 5AM Opportunities I, L.P. cashed out on 93,242,818 shares for a total of $48,880,661.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+104.09%
4.08M
$20.00
—
7.99M
Nov 2
Form 3
—
0
—
—
0
No matching records found

Pear Therapeutics, Inc. (PEARQ) Snapshot price: $0.0002

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-98.81%
-16.54M
$0.12
-$1,985,293.56
200K
Apr 10
Form 4
-0.78%
-105.28K
$2.74
-$288,267.28
13.37M
Nov 11 - Nov 15
Form 4
-0.40%
-54.21K
$2.77
-$150,095.68
13.48M
Oct 31 - Nov 2
Form 4
-3.96%
-558.17K
$1.88
-$1,047,321.73
13.53M
Sep 14 - Sep 16
Form 4
-5.18%
-770.00K
$2.05
-$1,581,834.98
14.09M
Sep 6 - Sep 8
Form 4
-2.62%
-400.00K
$1.65
-$660,059.58
14.86M
Aug 16 - Aug 18
Form 3
—
0
—
—
0
No matching records found

Rallybio Corp (RLYB) Snapshot price: $1.67

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.87%
-150.00K
$12.50
-$1,875,000.00
3.73M
Jun 3
Form 4
-2.51%
-100.00K
$13.00
-$1,300,000.00
3.88M
May 23
Form 4
-5.01%
-210.00K
$13.05
-$2,740,500.00
3.98M
Feb 8
Form 4
+77.83%
615.38K
$13.00
$7,999,992.00
1.41M
Aug 2
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Akouos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.14M
—
—
0
Nov 30
Form 4
-10.20%
-470.00K
$18.00
-$8,460,000.00
4.14M
Dec 29
Form 4
∞
4.61M
$17.00
—
4.61M
Jun 30
Form 3
—
0
—
—
0
No matching records found

scPharmaceuticals Inc. (SCPH) Snapshot price: $5.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.99%
-600.00K
$4.15
-$2,488,906.62
2.73M
Oct 6 - Oct 10
Form 4
-6.36%
-226.62K
$4.84
-$1,096,953.44
3.33M
Sep 6 - Sep 7
Form 4
-7.05%
-270.00K
$5.00
-$1,350,000.00
3.56M
Apr 11
Form 3
—
0
—
—
0
No matching records found